Implantable Pulse Generator Market Report
Implantable Pulse Generator Market, By Product (Implantable cardiac pacemakers, Implantable defibrillators, Cochlear implants, Implantable nerve stimulators (FES) [Limb function stimulation, Bladder stimulators, Sphincter stimulators, Diaphragm stimulators, Analgesia], Implantable infusion pumps, Implantable active monitoring devices), By Application (Neurovascular Diseases, Cardiovascular Diseases, Orthopedic), By End Use (Hospitals, Ambulatory Surgical Centers, Home Care Settings, Clinics) and Region - COVID-19 Impact Analysis and Forecast to 2026.
This market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the global implantable pulse generator market. The historic years considered for the study are 2016-2019, the base year is 2020, and the forecast period is 2021-2026.
Implantable Pulse Generator Market, By Product (Implantable cardiac pacemakers, Implantable defibrillators, Cochlear implants, Implantable nerve stimulators (FES) [Limb function stimulation, Bladder stimulators, Sphincter stimulators, Diaphragm stimulators, Analgesia], Implantable infusion pumps, Implantable active monitoring devices), By Application ...
Impact of COVID-19 on Implantable Pulse Generator Market
Covid-19 has impacted the market dynamics, competition, and global supply chain. The revenues have gone down in 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operation and strategy will sustain and beat the competition.
Note: The summary below might not have included insights on covid impact since we have large number of reports.
The Implantable Pulse Generator market is projected to grow from USD 85.2 billion in 2020 to USD 136.8 billion by 2026 at a CAGR of around 8.4% during the forecast period.
An implantable pulse generator is a battery-powered micro-electronic medical device that is implanted in the body, delivers electric stimulation to the nervous system to stimulate or block various nerve impulses in the body. This technology is a vital treatment for several medical conditions such as reducing back pain, hypertension, curing diabetes to stopping the dosage of insulin taken daily, and obesity.
Key players operating in the implantable pulse generator market are-
The growing prevalence of diseases and rising demand for innovative alternate therapies are some of the key factors augmenting the demand for implantable pulse generators. Also, other significant drivers propelling the increasing penetration of implantable pulse generators include ease of implants with good reimbursements, better clinical performance, higher patient awareness, and advancing technology. Moreover, the market is likely to grow at a steady pace due to rising use to treat a wide range of medical conditions and diseases during the review period.
By application, the implantable pulse generator market has been classified into neurovascular diseases, cardiovascular diseases, and orthopedic. Under these, the cardiovascular diseases segment accounted for a significant market share in 2020 and is projected to register significant growth during the review period. This is mainly attributed to growing incidences of cardiovascular diseases (CVDs), the rising cost of cardiac disease management, favorable government policies, and the emergence of technologically advanced pacemakers, which further fosters segment growth.
By region, the market in North America accounted for a significant market share in 2020 and is projected to grow at a significant CAGR during the assessment period. This is mainly ascribed to the rising prevalence of chronic ailments and cardiovascular diseases, robust healthcare infrastructure, the higher diagnosis rate of the patients, increasing healthcare expenditure, higher adoption of Neuromodulation in disease management, and a large number of home healthcare facilities, which further proliferates the regional market growth.
The COVID-19 outbreak positively influenced the implantable pulse generator market growth. The novel coronavirus had severely affected patients suffering from cardiovascular diseases. The spread of COVID-19 had triggered a severe economic impact on the healthcare sector. Among patients with COVID-19, there is a high prevalence of cardiovascular diseases, thus driving the market growth amid the pandemic.
Here is the list of the group of customers that the implantable pulse generator market hopes to have the greatest opportunity to convert-
Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at firstname.lastname@example.org.
The implantable pulse generator market is expected to witness an impressive growth of 8.4% CAGR in the coming years.
Medtronic (Ireland), Boston Scientific Corporation (US), St. Jude Medical (US), Synapse Biomedi-cal (US), Nevro Corporation (US), Neurosigma (US), Neuropace (US), Cyberonics (US), and Bio-Control Medical (Israel) are among the key players in the implantable pulse generator market.
The implantable pulse generator market size is expected to reach USD 136.8 billion in the foreseeable future.
The cardiovascular diseases segment is expected to register significant growth in the implantable pulse generator market in the next five years.
North America is expected to grow at a significant CAGR in the implantable pulse generator market in the foreseeable years.
Implantable Pulse Generator distributors, Implantable Pulse Generator suppliers, Implantable Pulse Generator manufacturers, Logistics organizations, Government bodies are the target audience in the implantable